Arcadia Biosciences (NASDAQ:RKDA) Stock Passes Below 50 Day Moving Average – Time to Sell?

Arcadia Biosciences, Inc. (NASDAQ:RKDA) shares crossed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.98 and traded as low as $2.18. Arcadia Biosciences shares last traded at $2.18, with a volume of 38,027 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Arcadia Biosciences in a research note on Monday, December 29th. One analyst has rated the stock with a Sell rating, According to MarketBeat, Arcadia Biosciences presently has an average rating of “Sell”.

Arcadia Biosciences Stock Down 2.2%

The company has a 50 day moving average of $2.98 and a two-hundred day moving average of $3.61. The firm has a market cap of $2.99 million, a P/E ratio of 0.86 and a beta of 0.57.

Arcadia Biosciences (NASDAQ:RKDA) last issued its quarterly earnings results on Friday, November 7th. The basic materials company reported $0.62 EPS for the quarter, topping the consensus estimate of ($0.54) by $1.16. Arcadia Biosciences had a negative net margin of 97.97% and a negative return on equity of 8.80%. The firm had revenue of $1.30 million for the quarter, compared to analysts’ expectations of $1.90 million.

About Arcadia Biosciences

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.